Yi Du

发表

Cancer Therapy: Preclinical Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells

R. Herbst, M. Hung, Shih-Shin Chang, 2013 .

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

M. Hung, S. Tsai, I. Fidler, 2010, Science Signaling.

EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2

Yan Wang, Dinshaw J. Patel, D. Patel, 2013, Nature.

H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism

M. Hung, Lin-lin Sun, J. Hsu, 2019, The Journal of Biological Chemistry.

KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.

M. Hung, S. Tsai, Chia-Wei Li, 2009, Molecular cell.

Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: Effects on insulin-like growth factor I signaling (Molecular Cancer Therapeutics (2007) 6, (667-674))

R. Nahta, F. Esteva, Yi Du, 2008 .

Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis.

G. Mills, M. Hung, W. Xia, 2010, Cancer research.

elerates Mammary Tumorigenesis

G. Mills, M. Hung, W. Xia, 2010 .

ivation of Murine Double Minute 2 by Akt in Mammary helium Delays Mammary Involution and R elerates Mammary Tumorigenesis

G. Mills, M. Hung, W. Xia, 2010 .

Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling

R. Nahta, F. Esteva, Yi Du, 2007, Molecular Cancer Therapeutics.

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

G. Hortobagyi, M. Hung, Seung-Oe Lim, 2017, Clinical Cancer Research.

Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase

G. Hortobagyi, M. Hung, W. Xia, 2011, Molecular Cancer Therapeutics.

1 Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin-Cytosine Deaminase-Uracil Phosphoribosyl Transferase

Yan, G. Hortobagyi, M. Hung, 2011 .

PARP inhibitors as precision medicine for cancer treatment

M. Hung, J. Hsu, H. Yamaguchi, 2017 .

MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.

M. Hung, Yun-Ju Lai, Chunxiao Liu, 2019, Gastroenterology.

Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors

Chien-Liang Liu, Morag Park, Hirohito Yamaguchi, 2016, Nature Medicine.

Nuclear Functions of Receptor Tyrosine Kinases

M. Hung, J. Hsu, Yi Du, 2015 .

Syntaxin 6- and microtubule- mediated intracellular trafficking contributes to Golgi and nuclear translocation of EGFR

Yi Du, 2012 .

Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer

M. Hung, W. Xia, Yongkun Wei, 2009, Molecular carcinogenesis.

EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.

M. Hung, Chunxiao Liu, Yufan Qiu, 2018, Cancer research.

Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts

Xin Hu, P. Friedl, P. Khong, 2019, bioRxiv.

A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma.

R. DePinho, R. Bouchard, M. Hung, 2017, American journal of cancer research.

Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

G. Hortobagyi, M. Hung, J. Hsu, 2012, Molecular Cancer Therapeutics.

Preclinical Development Targeting the IKK b / mTOR / VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

G. Hortobagyi, M. Hung, J. Hsu, 2012 .

Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

Jun Yao, G. Hortobagyi, L. Nie, 2015, American journal of translational research.

The Translocon Sec61β Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus*

M. Hung, J. Hsu, Heng-Huan Lee, 2010, The Journal of Biological Chemistry.

IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.

M. Karin, M. Hung, J. Hsu, 2012, Molecules and Cells.

Membrane-bound Trafficking Regulates Nuclear Transport of Integral Epidermal Growth Factor Receptor (EGFR) and ErbB-2*

M. Hung, Heng-Huan Lee, H. Yamaguchi, 2012, The Journal of Biological Chemistry.

Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells

R. Herbst, M. Hung, Shih-Shin Chang, 2013, Clinical Cancer Research.

Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.

G. Hortobagyi, J. Engelman, M. Andreeff, 2010, Cancer research.

BCL9 enhances the development of cervical carcinoma by deactivating CPEB3/EGFR axis

Yi Du, Lei Shi, Juan Li, 2022, Tropical Journal of Pharmaceutical Research.

EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis

A. Sood, C. Ivan, Yi Du, 2018, Oncogene.

PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner

Yi Du, L. Qiu, Wendong Yao, 2022, Molecular Biology Reports.

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Jun Yao, G. Hortobagyi, L. Nie, 2017, Oncogene.

MicroRNA-3713 regulates bladder cell invasion via MMP9

Hao Li, Yi Du, Hai-tao Liu, 2016, Scientific Reports.